We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Polymer Film Packed with Antibodies Used to Capture Tumor Cells

By LabMedica International staff writers
Posted on 15 Mar 2012
Print article
Image: The polymer film forms nanodots: tiny bumps that can be functionalized with antibodies to grab passing cancer cells (Photo courtesy of WILEY-VHC Verlag GmbH & Co.).
Image: The polymer film forms nanodots: tiny bumps that can be functionalized with antibodies to grab passing cancer cells (Photo courtesy of WILEY-VHC Verlag GmbH & Co.).
The development of polymer film packed with antibodies that can grab tumor cells demonstrates potential as an effective diagnostic tool.

Metastasis, the process when cancer cells that break free from a tumor and circulate through the bloodstream spread cancer to other parts of the body, is extremely difficult to monitor because the circulating tumor cells (CTCs) can account for as few as one in every billion blood cells.

Research led by scientists from the RIKEN Advanced Science Institute (Wako, Japan), in collaboration with colleagues at the University of California, Los Angeles (UCLA; USA) and the Institute of Chemistry at the Chinese Academy of Sciences (Beijing, China), has created a polymer film that can capture specific CTCs. With additional modifications, the system could help clinicians to identify an advancing cancer and assess the effectiveness of treatments.

The researchers utilized a small electrical voltage to help deposit a conducting polymer film of poly(3,4-ethylenedioxythiophene) (PEDOT) bearing carboxylic acid groups on to a 2-cm2 glass base. The polymer formed nanodots, minuscule bumps that measure 100-300 nm across, depending on the voltage used (1-1.4 V).

Adding a chemical linker to the film allowed it to bind a protein called streptavidin; this protein then joined to an antibody. After that, the antibody could latch on to an antigen called epithelial cell adhesion molecule (EpCAM), which is generated by most tumor cells. In this manner, the film could capture tumor cells from only a couple of milliliters of a blood sample.

The scientists evaluated several types of tumor cells on films with various sizes and densities of nanodots, and used a microscope to observe how well they captured the cells. The most effective film, with nanodots measuring about 230 nm across and containing about 8 dots per square micrometer, captured approximately 240 breast-cancer cells per mm2 of film. In contrast, it captured fewer than 30 cervical cancer cells that do not express EpCAM, proving that the antibody used on the film is highly selective. A smooth PEDOT-carboxylic acid film with the same antibody captured only about 50 breast cancer cells.

The film’s effectiveness depends on the size and spacing of the nanodots, and the presence of the capturing antibody. Because these can be easily modified, the same application could be used to produce films that sense other types of cells.

The next phase of the research is to “further optimize the nanostructures of the conducting polymers and understand in more detail the cell-capturing mechanism,” said RIKEN unit leader Hsiao-hua Yu. “We are also currently working on a direct electrical readout of the captured cells, without needing to use a microscope.”

The study’s findings were published November 2, 2012, in the journal Advanced Materials.

Related Links:

RIKEN Advanced Science Institute
University of California, Los Angeles
Institute of Chemistry at the Chinese Academy of Sciences


New
Gold Member
ANA & ENA Screening Assays
ANA and ENA Assays
Automated Blood Typing System
IH-500 NEXT
New
Gold Member
Pneumocystis Jirovecii Detection Kit
Pneumocystis Jirovecii Real Time RT-PCR Kit
New
UHF RFID Tag and Inlay
AD-321r6/AD-321r6-P

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Technology

view channel
Image: Schematic diagram of nanomaterial-based anti-epileptic drug concentration diagnostic technology (Photo courtesy of KRISS)

Nanomaterial-Based Diagnostic Technology Accurately Monitors Drug Therapy in Epilepsy Patients

Many patients with epilepsy take anti-epileptic drugs to control frequent seizures in their daily lives. To optimize treatment and avoid side effects from overdosing, it is crucial for patients to regularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.